Purification and characterization of antistaphylococcal substance from Pseudomonas sp. KUH-001

Journal of Microbiology and Biotechnology

Volumn 8, Issue 2, 1998, Pages 111-118

  Hwang, S E Young ^a   Lee, S O Hee ^a   Song, Kook Jong ^a   Kim, Yong Pil ^a   Kawahara, Kazuyoshi ^b  

^a Korea University   (South Korea)

^b KITASATO INSTITUTE   (Japan)

Author keywords

2 Heptyl 4 hydroxyquinoline N oxide; Antistaphylococcal antibiotics; Pseudomonas sp.

Indexed keywords

2 HEPTYL 4 HYDROXYQUINOLINE 1 OXIDE;

ANTIMICROBIAL ACTIVITY; ARTICLE; DRUG ISOLATION; DRUG STRUCTURE; NONHUMAN; PSEUDOMONAS; STAPHYLOCOCCUS AUREUS; TAXONOMY;

PSEUDOMONAS;

EID: 0031833448     PISSN: 10177825     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Boyce, J. M. 1991. Patterns of methicillin-resistant Staphylococcus aureus prevalence. Infect Control Hosp. Epidemiol. 12: 79-82.
2. Carrelts, J. C. and J. D. Peterie. 1985. Vancomycin and the red man's syndrome. N. Engl. J. Med. 312: 245.
3. Comforth, J. W. and A. T. James. 1951. Structure of a naturally occurring antagonist of dihydrostreptomycin. Biochem. J. 63: 124-129.
4. Cunha, B. A. and A. M. Ristuccia. 1983. Clinical usefulness of vancomycin. Clin. Pharm. 2: 417-424.
5. Cunha, B. A., R. Quintiliani, J. M. Deglin, M. W. Izard, and C. H. Nightingale. 1981. Pharmacokinetics of vancomycin in anuria. Rev. Infect. Dis. 3: Suppl. S269-S272.
6. Farber, B. F. and R. C. Moellering,-Jr. 1983. Retrospetive study of the toxicity of preparations of vancomycin from 1974 to 1981. Antimicrob. Agents Chemother. 23: 138-141.
7. Fung, T. J., E. Huczko, E. Gradelski, K. Denbleyker, D. P. Bonner, and R. E. Kessler. 1991. Emergence of homogeneously methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 29: 2880-2883.
8. Grundon, M. F. 1979. In R. H. F. Manske and R. Rodrigo (ed.). The Alkaloids, Vol. XVII, p. 177. Academic Press, New York.
9. Hays, E. E., I. C. Wells, P. A. Katzman, C. K. Cain, F. A. Jacobs, S. A. Tkayer, E. A. Doisy, W. L. Gaby, K. C. Roberts, R. D. Muir, C. J. Carroll, L. R. Jones, and R. J. Wade. 1945. Antibiotic substances produced by Pseudomonas aeruginosa. J. Biol. Chem. 159: 725-750.
10. Hwang, S. Y., D. A. Berges, J. J. Taggart, and C. Gilvarg. 1989. Portage transport of sulfanilamide and sulfanilic acid. J. Med. Chem. 32: 694-698.
11. Hwang, S. Y., M. R. Ki, S. Y. Cho, and I. D. Yoo. 1995. Transport of sulfanilic acid via microbial dipeptide transport system, J. Microbiol. Biotechnol. 5: 315-318.
12. Hwang, S. Y., M. R. Ki, S. Y. Cho, W. J. Lim, and I. D. Yoo. 1996. Competitive spectrophotometry for microbial dipeptide transport systems. J. Microbiol. Biotechnol. 6: 92-97.
13. Jarvis, W. R., J. W. White, and V. P. Munm. 1984. Nosocomial infection surveillance - 1983. Morb. Mortal. Wkly. Rep. 33: 9SS.
14. James, J. R. 1986. Treatment of methicillin-resistant staphylococcal infections (Chapt. 44). pp. 489-514. In Peterson, P. K. and J. Verhoef (ed.), The Antimicrobial Agents, Annual 1. Elsevier Pub. Co.
15. Kaye, D. 1980. The clinical significance of tolerance of Staphylococcus aureus. Ann. Intern. Med. 93: 924.
16. Lightbown, J. W. and F. L. Jackson. 1956. Inhibition of cytochrome systems of heart muscle and certain bacteria by the antagonists of dihydrostreptomycin: 2-alkyl-4-hydroxyquinoline N-oxides. Biochem. J. 63: 130-137.
17. Ling, J. M., A. W. Lam, A. F. Cheng, and G. L. French. 1993. Activity of beta-lactam antibiotics in an animal model against methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 32: 919-920.
18. Machan, A., T. L. Pitt, D. White, D. Watson, G. W. Taylor, P. J. Cole, and R. Wilson. 1991. Interaction between Pseudomonas aerugmosa and Staphylococcus aureus: description of an antistaphylococcal substance. J. Med. Microbiol. 34: 213-217.
19. Ooishi, -M. 1990. MRSA ocular infections. Folia. Ohpthalmol. Jap. 41:18-25.
20. Openshaw, H. T. 1953. In Manske, R. H. F. and H. L. Holmes (ed.), The Alkaloids. Vol. III. p. 65. Academic Press, Inc., New York.
21. Oyaizu, K. and K. Komagata. 1983. Grouping of Pseudomonas species on the basis of cellular fatty acid composition and the quinone system with special reference to the existence of 3-hydroxy fatty acid. J. Gen. Microbiol. 29: 17-40.
22. Rahal, -Jr. J. J. 1984. Staphylococcus aureus. N. Engl. J. Med. 311: 796.
23. Rogers, D. E. and R. Tompsett. 1952. The survival of staphylococci within human leukocytes. J. Exp. Med. 95: 209.
24. Smith, K. R. and C. G. Cobbs. 1992. In vitro activity of sparfloxacin and three other fluoroquinolones against methicillin-resistant Staphylacoccus aureus and Staphylococcus epidermidis. Clin. Microbiol. Inject Dis. 11: 55-58.
25. Somanathan, R. and K. M. Smith. 1981. Synthesis of some 2-alkyl-4-quinolone and 2-alkyl-4-methoxyquinone alkaloids. J. Heterocyclic Chem. 18: 1077-1079.
26. Stanier, R. Y., N. J. Palleroni, and M. Doudoroff. 1966. The aerobic Pseudomonads: A taxonomic study. J. Gen. Microbiol. 43: 159-271.
27. Wells, I. C. 1952. Antibiotic substances produced by Pseudomonas aeruginosa: synthesis of Pyo I b, Pyo I c, and Pyo III. J. Biol. Chem. 196: 231-339.
28. Wilson, W. R. 1986. Antimicrobial therapy of infective endocarditis (Chapt.39). pp. 420-435. In Peterson, P. K. and J. Verhoef (ed.), The Antimicrobial Agents, Annual 1. Elsevier Pub. Co.
29. Wilson, R., T. Pitt, G. Taylor, D. Watson, J. Macdermot, D. Sykes, D. Roberts, and P. Cole. 1987. Pyocyanin and 1-hydroxyphenazine produced by Pseudomonas aeruginosa inhibit the beating of human respiratory cilia in vitro. J. Clin. Invest. 79: 221-229.